Cargando…

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status

PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Fireman Klein, Einat, Adir, Yochai, Krencel, Amir, Peri, Regina, Vasserman, Bella, Fireman, Elizabeth, Kessel, Aharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402613/
https://www.ncbi.nlm.nih.gov/pubmed/30880945
http://dx.doi.org/10.2147/COPD.S187560
_version_ 1783400425898115072
author Fireman Klein, Einat
Adir, Yochai
Krencel, Amir
Peri, Regina
Vasserman, Bella
Fireman, Elizabeth
Kessel, Aharon
author_facet Fireman Klein, Einat
Adir, Yochai
Krencel, Amir
Peri, Regina
Vasserman, Bella
Fireman, Elizabeth
Kessel, Aharon
author_sort Fireman Klein, Einat
collection PubMed
description PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. METHODS: EBC was collected by conventional methods. Particles were analyzed with NanoSight LM20. EBC carbonyl and 8-hydroxydeoxyguanosine (8-OHdG) levels were measured using ELISA kits. Study population (58 COPD patients and 40 healthy smoker and non-smoker controls) underwent spirometry, diffusion capacity, EBC testing, and blood sampling. RESULTS: Absolute eosinophil count, C-reactive protein (CRP), and lactate dehydrogenase in serum were elevated in the COPD group compared with the controls (224 U/L, 5 mg/L, and 391 U/L vs 154 U/L, 3 mg/L, and 330 U/L, P=0.009, P=0.05, and P=0.004, respectively). COPD patients had lower UFP concentrations in EBC compared with controls (0.24 E8/mL vs 0.51 E8/mL, P≤0.001). A mirror image was detected in serum: COPD patients had higher UFP concentrations compared with controls (9.8 E8/mL vs 6.7 E8/mL, respectively, P=0.03). EBC carbonyl and 8-OHdG levels were higher among COPD patients compared with controls (5.1 per 1 µg/mL protein and 0.036 ng/mL vs 0.41 per 1 µg/mL protein and 0.003 ng/mL, P=0.001 and P≤0.001, respectively). EBC UFP concentrations were negatively correlated with pack years (R=−0.44, P ≤0.001) and positively correlated with FEV(1) and diffusing lung capacity for carbon monoxide (R=0.46, 0.23, P ≤0.001 and P=0.04, respectively). Low EBC UFP concentrations (≤0.18 E8/mL) and CRP levels ≥5 mg/L were independent predictors of the frequent exacerbator phenotype (OR 3.6; 95% CI: 1.06–7.97; P=0.04 and OR 4.4; 95% CI: 1.24–10.2; P=0.02, respectively). CONCLUSION: UFP content in EBC reflects the inflammatory state of airways. Low UFP concentrations in EBC and high in serum of COPD patients support our hypothesis that increased epithelial permeability could be the mechanism behind those findings.
format Online
Article
Text
id pubmed-6402613
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64026132019-03-16 Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status Fireman Klein, Einat Adir, Yochai Krencel, Amir Peri, Regina Vasserman, Bella Fireman, Elizabeth Kessel, Aharon Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. METHODS: EBC was collected by conventional methods. Particles were analyzed with NanoSight LM20. EBC carbonyl and 8-hydroxydeoxyguanosine (8-OHdG) levels were measured using ELISA kits. Study population (58 COPD patients and 40 healthy smoker and non-smoker controls) underwent spirometry, diffusion capacity, EBC testing, and blood sampling. RESULTS: Absolute eosinophil count, C-reactive protein (CRP), and lactate dehydrogenase in serum were elevated in the COPD group compared with the controls (224 U/L, 5 mg/L, and 391 U/L vs 154 U/L, 3 mg/L, and 330 U/L, P=0.009, P=0.05, and P=0.004, respectively). COPD patients had lower UFP concentrations in EBC compared with controls (0.24 E8/mL vs 0.51 E8/mL, P≤0.001). A mirror image was detected in serum: COPD patients had higher UFP concentrations compared with controls (9.8 E8/mL vs 6.7 E8/mL, respectively, P=0.03). EBC carbonyl and 8-OHdG levels were higher among COPD patients compared with controls (5.1 per 1 µg/mL protein and 0.036 ng/mL vs 0.41 per 1 µg/mL protein and 0.003 ng/mL, P=0.001 and P≤0.001, respectively). EBC UFP concentrations were negatively correlated with pack years (R=−0.44, P ≤0.001) and positively correlated with FEV(1) and diffusing lung capacity for carbon monoxide (R=0.46, 0.23, P ≤0.001 and P=0.04, respectively). Low EBC UFP concentrations (≤0.18 E8/mL) and CRP levels ≥5 mg/L were independent predictors of the frequent exacerbator phenotype (OR 3.6; 95% CI: 1.06–7.97; P=0.04 and OR 4.4; 95% CI: 1.24–10.2; P=0.02, respectively). CONCLUSION: UFP content in EBC reflects the inflammatory state of airways. Low UFP concentrations in EBC and high in serum of COPD patients support our hypothesis that increased epithelial permeability could be the mechanism behind those findings. Dove Medical Press 2019-03-01 /pmc/articles/PMC6402613/ /pubmed/30880945 http://dx.doi.org/10.2147/COPD.S187560 Text en © 2019 Fireman Klein et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Fireman Klein, Einat
Adir, Yochai
Krencel, Amir
Peri, Regina
Vasserman, Bella
Fireman, Elizabeth
Kessel, Aharon
Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title_full Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title_fullStr Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title_full_unstemmed Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title_short Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
title_sort ultrafine particles in airways: a novel marker of copd exacerbation risk and inflammatory status
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402613/
https://www.ncbi.nlm.nih.gov/pubmed/30880945
http://dx.doi.org/10.2147/COPD.S187560
work_keys_str_mv AT firemankleineinat ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT adiryochai ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT krencelamir ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT periregina ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT vassermanbella ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT firemanelizabeth ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus
AT kesselaharon ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus